Patient evidence in HTA: Does it matter?

How a “push and pull” approach can maximize innovation value through HTAs and associated reimbursement negotiations

Product launches: making the most of your one shot

How pharma can navigate ups and downs of vertical integration in US

Thriving in the post-COVID world in 2021 and beyond

Partnerships + acquisitions = better value propositions?